VIAF

Virtual International Authority File

Search

James P. Allison American immunologist and professor Wikidata

Allison, James P. National Library of Israel Sudoc [ABES], France National Library of the Netherlands National Library of Australia Library of Congress/NACO

James P. Allison American immunologist and academic ISNI

Allison, James P. 1948- German National Library

VIAF ID: 94665093 (Personal)

Permalink: http://viaf.org/viaf/94665093

Open Section Close Section Preferred Forms

 

 

 

 

Open Section Close Section 4xx's: Alternate Name Forms (26)

Open Section Close Section 5xx's: Related Names (1)

  • 551 _ _ ‎‡a  Alice‏ ‎‡4  ortg‏ ‎‡4  http://d-nb.info/standards/elementset/gnd#placeOfBirth German National Library

Open Section Close SectionWorks

Title Sources
Cancer immunotherapy Wikidata Sudoc [ABES], France
Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness. Wikidata
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells. Wikidata
The future of immune checkpoint therapy Wikidata
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. Wikidata
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Wikidata
Hybridomas and cellular immortality National Library of the Netherlands Library of Congress/NACO
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes Wikidata
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection. Wikidata
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Wikidata
Immune modulation in cancer with antibodies. Wikidata
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Wikidata
Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma. Wikidata
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Wikidata
Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy. Wikidata
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4. Wikidata
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection. Wikidata
Inhibitors of B7-CD28 costimulation in urologic malignancies. Wikidata
Insolubilization of L-asparaginase by covalent attachment to nylon tubing Wikidata
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Wikidata
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab Wikidata
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy. Wikidata
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity. Wikidata
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies. Wikidata
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. Wikidata
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: Identification of constant and variable peptides Wikidata
Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade. Wikidata
MHC class II-independent and -dependent T cell expansion and B cell hyperactivity in vivo in mice deficient in CD152 (CTLA-4). Wikidata
The mouse T cell receptor: structural heterogeneity of molecules of normal T cells defined by xenoantiserum Wikidata
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections. Wikidata
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Wikidata
Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Wikidata
Nobels: Toll pioneers deserve recognition. Wikidata
Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses. Wikidata
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors Wikidata
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells Wikidata
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies Wikidata
Pillars article: CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. The journal of experimental medicine. 1995. 182: 459-465. Wikidata
A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Wikidata
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy Wikidata
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial. Wikidata
The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Wikidata
Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Wikidata
Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Wikidata
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Wikidata
Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint Wikidata
Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Wikidata
Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer. Wikidata
Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe". Wikidata
Restoring function in exhausted CD8 T cells during chronic viral infection Wikidata
Retrospective. Lloyd J. Old (1933-2011). Wikidata
Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Wikidata
Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report Wikidata
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stage Wikidata
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication. Wikidata
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Wikidata
Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance Wikidata
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival Wikidata
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade. Wikidata
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Wikidata
Strength of TCR-peptide/MHC interactions and in vivo T cell responses. Wikidata
The substrate specificity of L-asparaginase from Alcaligenes eutrophus Wikidata
Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy. Wikidata
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin Wikidata
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function. Wikidata
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface Wikidata
T cell receptor-triggered activation of intraepithelial lymphocytes in vitro Wikidata
T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine. Wikidata
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. Wikidata
TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence. Wikidata
Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity. Wikidata
To be or not to be B7. Wikidata
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. Wikidata
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner. Wikidata
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts Wikidata
Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982. Wikidata
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. Wikidata
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine. Wikidata

Open Section Close Section Selected Co-authors

Open Section Close Section Countries and Regions of Publication (2)

Open Section Close Section Publication Statistics

Open Section Close Section Selected Publishers (2)

Open Section Close Section About

Open Section Close Section History of VIAF ID:94665093 (10)